Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | 1A46 |
Trade Name | |
Synonyms | CMG1A46|CMG 1A46|CMG-1A46 |
Drug Descriptions |
1A46 is a trispecific antibody that targets tumor-expressed CD19 and CD20, and T cell-expressed CD3, which potentially leads to an enhanced cytotoxic T-lymphocyte (CTL) response against tumor cells expressing CD19 and CD20 (NCI Drug Dictionary). |
DrugClasses | CD19 Antibody 21 CD20 Antibody 24 CD3 Antibody 99 |
CAS Registry Number | NA |
NCIT ID | C188959 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
1A46 | 1A46 | 0 | 1 |